» Articles » PMID: 11413129

Proteinase-activated Receptor-2-mediated Activation of Stress-activated Protein Kinases and Inhibitory Kappa B Kinases in NCTC 2544 Keratinocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Jun 20
PMID 11413129
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

In this study we examined the regulation of the stress-activated protein (SAP) kinases and inhibitory kappa B kinases (IKKs) through stimulation of the novel G-protein-coupled receptor proteinase-activated receptor-2 in the human keratinocyte cell line NCTC2544. Trypsin and the peptide SLIGKV stimulated a time-dependent increase in both c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activity. Trypsin also stimulated NF kappa B-DNA binding and the activation of the upstream kinases IKK alpha and -beta. Phorbol 12-myristate 13-acetate also strongly activated both SAP kinases and IKK isoforms, suggesting the potential for a protein kinase C-mediated regulatory mechanism underlying the effects of trypsin. Pre-incubation with selective protein kinase C (PKC) inhibitors GF109203X and Gö6983, or transfection of dominant negative (DN)-PKC alpha, abolished phorbol 12-myristate 13-acetate-mediated c-Jun N-terminal kinase activity, although it only partially inhibited the response to trypsin. In contrast, Gö6983 reduced trypsin-stimulated p38 mitogen-activated protein kinase activity to a greater extent than GF109203X, although DN-PKC alpha or PKC zeta had no substantial effect. Additionally, inhibitors of PKC partially reduced trypsin-stimulated IKK alpha activity but abolished that of IKK beta, whereas DN-PKC alpha but not DN-PKC zeta substantially reduced trypsin-stimulated Flag-IKK beta activity. This study shows for the first time proteinase-activated receptor-2-mediated stimulation of both SAP kinase and IKK signaling and differing roles for PKC isoforms in the regulation of each pathway.

Citing Articles

Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives.

Fan M, Fan X, Lai Y, Chen J, Peng Y, Peng Y Front Immunol. 2024; 15:1448952.

PMID: 39301020 PMC: 11410643. DOI: 10.3389/fimmu.2024.1448952.


Par2-mediated responses in inflammation and regeneration: choosing between repair and damage.

Reches G, Piran R Inflamm Regen. 2024; 44(1):26.

PMID: 38816842 PMC: 11138036. DOI: 10.1186/s41232-024-00338-1.


Endothelial PAR2 activation evokes resistance artery relaxation.

Zhang X, Lee M, Buckley C, Hollenberg M, Wilson C, McCarron J J Cell Physiol. 2023; 238(4):776-789.

PMID: 36791026 PMC: 10952239. DOI: 10.1002/jcp.30973.


Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX.

Ma J, Scott C, Ho Y, Mahabaleshwar H, Marsay K, Zhang C Elife. 2021; 10.

PMID: 34165081 PMC: 8291973. DOI: 10.7554/eLife.66596.


A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

Gordon D, Jang G, Bouhaddou M, Xu J, Obernier K, OMeara M bioRxiv. 2020; .

PMID: 32511329 PMC: 7239059. DOI: 10.1101/2020.03.22.002386.